Inventor · disambiguated record
Kang Sun
Also filed as: SUN KANG
6 granted patents·3 pending applications·6 citations·filing 2020–2023
75Inventor score
Files withINCYTE CORP9
Top patents by PatentIndex Score
9 records- 0190US11590137B2Ruxolitinib formulation for reduction of itch in atopic dermatitisINCYTE CORP·Filed 2022·Granted Feb 28, 2023·2 cites·27 claims
- 0287US11510923B2Ruxolitinib formulation for reduction of itch in atopic dermatitisINCYTE CORP·Filed 2020·Granted Nov 29, 2022·2 cites·18 claims
- 0386US11602536B2Topical treatment of vitiligo by a JAK inhibitorINCYTE CORP·Filed 2020·Granted Mar 14, 2023·2 cites·23 claims
- 0477US12396993B2Ruxolitinib formulation for reduction of itch in atopic dermatitisINCYTE CORP·Filed 2022·Granted Aug 26, 2025·0 cites·25 claims
- 0576US12233067B2Topical treatment of vitiligo by a JAK inhibitorINCYTE CORP·Filed 2022·Granted Feb 25, 2025·0 cites·15 claims
- 0673US11590138B2Topical treatment of vitiligo by a jak inhibitorINCYTE CORP·Filed 2022·Granted Feb 28, 2023·0 cites·21 claims
- 0768US2023293431A1Topical treatment of vitiligo by a jak inhibitorINCYTE CORP·Filed 2023·Application pending·0 cites
- 0861US2023364095A1Topical treatment of vitiligoINCYTE CORP·Filed 2021·Application pending·0 cites
- 0949US2021030672A1Topical treatment of vitiligo by a jak inhibitorINCYTE CORP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kang Sun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →